Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis

被引:21
作者
van Laar, JAM
Buysse, CMP
Vossen, ACTM
Hjálmarsson, B
van den Berg, B
van Lom, K
Deinum, J
机构
[1] Univ Rotterdam Hosp, Dept Internal Med, Rotterdam, Netherlands
[2] Univ Rotterdam Hosp, Dept Pediat, Rotterdam, Netherlands
[3] Univ Rotterdam Hosp, Dept Virol, Rotterdam, Netherlands
[4] Univ Rotterdam Hosp, Dept Pulm & Crit Care Med, Rotterdam, Netherlands
[5] Univ Rotterdam Hosp, Dept Hematol, Rotterdam, Netherlands
关键词
D O I
10.1001/archinte.162.7.837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe 2 immunocompetent adolescents with fulminant infectious mononucleosis and virus-associated hemophagocytosis. A new quantitative polymerase chain reaction revealed high serum Epstein-Barr virus DNA levels in these patients. One patient died with an increasing viral load not responding to corticosteroids followed by antiviral and intensified immunomodulatory treatment. The other patient received corticosteroids and acyclovir at diagnosis; her rapid recovery was heralded by a steep decline of viral load. We propose monitoring the clinical course of fulminant infectious mononucleosis in immunocompetent patients by Epstein-Barr virus DNA quantification and prompt corticosteroid and antiviral therapy when viral load is high.
引用
收藏
页码:837 / 839
页数:3
相关论文
共 7 条
[1]   Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease:: prophylactic infusion of EBV-specific cytotoxic T cells [J].
Gustafsson, Å ;
Levitsky, V ;
Zou, JZ ;
Frisan, T ;
Dalianis, T ;
Ljungman, P ;
Ringden, O ;
Winiarski, J ;
Ernberg, I ;
Masucci, MG .
BLOOD, 2000, 95 (03) :807-814
[2]   Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis [J].
Imashuku, S ;
Kuriyama, K ;
Teramura, T ;
Ishii, E ;
Kinugawa, N ;
Kato, M ;
Sako, M ;
Hibi, S .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2665-2673
[3]  
Imashuku S, 1997, INT J HEMATOL, V66, P135
[4]  
KIKUTA H, 1993, BLOOD, V82, P3259
[5]  
MROCZEK EC, 1987, ARCH PATHOL LAB MED, V111, P530
[6]   Development of a real-time quantitative assay for detection of Epstein-Barr virus [J].
Niesters, HGM ;
van Esser, J ;
Fries, E ;
Wolthers, KC ;
Cornelissen, J ;
Osterhaus, ADME .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :712-715
[7]   DETECTION AND QUANTIFICATION OF VIRUS-DNA IN PLASMA OF PATIENTS WITH EPSTEIN-BARR VIRUS-ASSOCIATED DISEASES [J].
YAMAMOTO, M ;
KIMURA, H ;
HIRONAKA, T ;
HIRAI, K ;
HASEGAWA, S ;
KUZUSHIMA, K ;
SHIBATA, M ;
MORISHIMA, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (07) :1765-1768